Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas

Erkan Topkan,1 Ugur Selek,2,3 Ahmet Kucuk,4 Berrin Pehlivan5 1Department of Radiation Oncology, Baskent University Medical Faculty, Adana, Turkey; 2Department of Radiation Oncology, Koc University School of Medicine, Istanbul, Turkey; 3Division of Radiation Oncology, The University of Texas MD Ander...

Full description

Bibliographic Details
Main Authors: Topkan E, Selek U, Kucuk A, Pehlivan B
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/low-pre-chemoradiotherapypan-immune-inflammation-value-piv-measures-pr-peer-reviewed-fulltext-article-JIR